M&A  January 5, 2024

SomaLogic merger overcomes investor objections to win shareholder approval

Graham Street Realty recently sold the Boulder office space occupied by blood-protein testmaker SomaLogic Inc. for $12.5 million. Courtesy Graham Street Realty.
By

BOULDER — SomaLogic Inc. (Nasdaq: SLGC) said Thursday evening that its $1 billion merger with California-based Standard BioTools Inc. (Nasdaq: LAB) is expected to be finalized Friday after shareholders for the Boulder biotech company voted this week to consummate the combination. 

The apparent approval came despite opposition from investors, including from private-equity firms that hold significant positions in the company as well as from SomaLogic’s founder and its chief technology officer.

“We are grateful for the support of our stockholders as we advance our value-maximizing transaction with Standard BioTools, which will…

Ken Amundson retired from his position as managing editor of BizWest in May 2024 but has come back on a limited basis to report business news in Northern Colorado and the Boulder Valley. He has lived in Loveland and reported on issues in the region since 1987. Prior to Colorado, he reported and edited for news organizations in Minnesota and Iowa. He's a parent of two and grandparent of four, all of whom make their homes north of Denver. A news junkie at heart, he also enjoys competitive sports, especially the Rapids.
Categories: Today's News Life Sciences M&A Sunday Weekly Boulder County Business Hall of Fame SomaLogic Inc. Standard BioTools Inc.

Related Posts

Sign up for BizWest Daily Alerts